HHS Logo [ [link removed] ]

Blue Gradient


Change in Preferred Drug List Status for Antihyperuricemics Drug Class

On April 22, 2024, the Texas Health and Human Services Commission (HHSC) removed the non-preferred status from products with the brand name Mitigare [ [link removed] ] on the HHSC preferred drug list.


* *Information for drug manufacturers:*
* eCOI Portal training materials available [ [link removed] ]

* *Information for pharmacies:*
* Provider Portal training materials available [ [link removed] ]
* Pharmacy Education Information and Opportunities [ [link removed] ]
* Pharmacy Email Addresses Must Be Current in PEMS [ [link removed] ]

* *Information for prescribers:*
* Prescriber Survey Opportunity About Texas Prescription Drug Monitoring Program Ends May 14 [ [link removed] ]









________________________________________________________________________

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website [ [link removed] ].

________________________________________________________________________

Stay Connected Visit us on Facebook [ [link removed] ] Visit us on YouTube [ [link removed] ] Visit us on Twitter [ [link removed] ] Visit us on Instagram [ [link removed] ] Visit us on Facebook [ [link removed] ]  (en español)  

Bookmark and Share [ [link removed] ]

Subscriber Services
Manage Preferences [ [link removed] ]  |  Unsubscribe [ [link removed] ]  |  Help [ [link removed] ]

________________________________________________________________________

This email was sent to [email protected] using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202 GovDelivery logo [ [link removed] ]